【査読付き英文論文】

*1. Toyokawa G, Takada K, Tagawa T, Hamamoto R, Yamada Y, Shimokawa M, Oda Y, Maehara Y: A positive correlation between the EZH2 and PD-L1 expression in resected lung adenocarcinoma. The Annals of Thoracic Surgery, 9, 34320-34335 (2019) [pubmed]

*2. Kim SK, Kim K, Ryu JW, Ryu TY, Lim JH, Oh JH, Min JK, Jung CR, Hamamoto R, Son MY, Kim DS, Cho HS: The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer. International Journal of Oncology, 54, 65-76 (2019) [pubmed]

*3. Kukita A, Sone K, Oda K, Hamamoto R, Kaneko S, Komatsu M, Wada M, Honjoh H, Kawata Y, Kojima M, Oki S, Sato M, Asada K, Taguchi A, Miyasaka A, Tanikawa M, Nagasaka K, Matsumoto Y, Hiraike O, Osuga Y, Fujii T: Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas. Biochemical and Biophysical Research Communications, 513, 340-346 (2019) [pubmed]

*4. Kojima M, Sone K, Oda K, Hamamoto R, Kaneko S, Oki S, Kukita A, Machino H, Honjoh H, Kawata Y, Kashiyama T, Asada K, Tanikawa M, Mori-Uchino M, Tsuruga T, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Osuga Y, Fujii T: The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation. BMC Cancer, 19, 455 (2019) [pubmed]

*5. Kobayashi K, Murakami N, Takahashi K, Inaba K, Hamamoto R, Itami J: Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation. In Vivo, 33, 1659-1665 (2019) [pubmed]

*6. Matsuno Y, Atsumi Y, Shimizu A, Katayama K, Fujimori H, Hyodo M, Minakawa Y, Nakatsu Y, Kaneko S, Hamamoto R, Shimamura T, Miyano S, Tsuzuki T, Hanaoka F, Yoshioka KI: Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro. Nature Communications, 10, 3925 (2019) [pubmed]

*7. Yamada M, Saito Y, Imaoka H, Saiko M, Yamada S, Kondo H, Takamaru H, Sakamoto T, Sese J, Kuchiba A, Shibata T, Hamamoto R: Developmentof a real-time endoscopic image diagnosis support system using deep learning technology in colonoscopy. Scientific Reports, 9, 14465 (2019) [pubmed]

*8. Kobayashi K, Murakami N, Takahashi K, Inaba K, Igaki H, Hamamoto R, Itami J:A Population-based Statistical Model for Investigating Heterogeneous intraprostatic Sensitivity to Radiation Toxicity After ¹²⁵I Seed Implantation. In Vivo, 33, 2103-2111 (2019) [pubmed]

*9. Kim S, Bolatkan A, Kaneko S, Ikawa N, Asada K, Komatsu M, Hayami S, Ojima H, Abe N, Yamaue H, Hamamoto R: Deregulation of the histone lysine specific demethylase 1 is involved in human hepatocellular carcinoma. Biomolecules, 9, 810 (2019) [pubmed]

【和文総説・書籍など】

*1. 浜本　隆二：AI技術を用いた統合的ながん医療システムの開発と解決すべき問題点. 最新医学, 74, 72-79 (2019)

*2. 浜本　隆二：ヘルスケア分野におけるAI活用の現状と展望. 臨床栄養, 134, 26-30 (2019)